These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2489233)
1. Novel inhibitors of enkephalin-degrading enzymes. II: N5'-substituted-4-thioxohydantoic acids as aminopeptidase inhibitors. Yu Z; Williams PS; Smith HJ; Sewell RD; Patel A; Gonzalez JP J Enzyme Inhib; 1989; 3(2):103-17. PubMed ID: 2489233 [TBL] [Abstract][Full Text] [Related]
2. 2-substituted-N5-(2'-aminophenyl)-4-thiohydantoic acids as aminopeptidase inhibitors with pro-antinociceptive activity. Yu Z; Williams PS; Patel A; Smith HJ; Sewell RD; Gonzalez JP Prog Clin Biol Res; 1990; 328():481-4. PubMed ID: 2406761 [No Abstract] [Full Text] [Related]
3. Hypoalgesic action of bestatin analogues that inhibit central aminopeptidases, but not neutral endopeptidase. Otero MJ; Iglesias T; Fuentes JA Neuropeptides; 1993 Sep; 25(3):175-82. PubMed ID: 8247255 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in mice. Reche I; Ruiz-Gayo M; Fuentes JA Neuropharmacology; 1998; 37(2):215-22. PubMed ID: 9680246 [TBL] [Abstract][Full Text] [Related]
5. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Michael-Titus A; Dourmap N; Costentin J; Schwartz JC Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590 [TBL] [Abstract][Full Text] [Related]
7. Novel inhibitors of enkephalin-degrading enzymes. I: Inhibitors of enkephalinase by penicillins. Williams PS; Sewell RD; Smith HJ; Gonzalez JP J Enzyme Inhib; 1989; 3(2):91-101. PubMed ID: 2489237 [TBL] [Abstract][Full Text] [Related]
8. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes. Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779 [TBL] [Abstract][Full Text] [Related]
12. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia. Reggiani A; Carenzi A; Frigeni V; Della Bella D Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939 [TBL] [Abstract][Full Text] [Related]
13. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492 [TBL] [Abstract][Full Text] [Related]
14. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin. Llorens-Cortes C; Schwartz JC Eur J Pharmacol; 1984 Sep; 104(3-4):369-74. PubMed ID: 6594244 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). Nabeshima T; Katoh A; Kameyama T J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094 [TBL] [Abstract][Full Text] [Related]
16. Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala. Gregoriou GC; Patel SD; Winters BL; Bagley EE Mol Pharmacol; 2020 Oct; 98(4):454-461. PubMed ID: 32606204 [TBL] [Abstract][Full Text] [Related]
17. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes. Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909 [TBL] [Abstract][Full Text] [Related]
18. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Giros B; Gros C; Solhonne B; Schwartz JC Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404 [TBL] [Abstract][Full Text] [Related]
19. Effect of inhibition of neuropeptidases on the pain threshold of mice and rats. Carenzi A; Frigeni V; Reggiani A; Della Bella D Neuropharmacology; 1983 Nov; 22(11):1315-9. PubMed ID: 6363960 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]